These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33419525)

  • 21. Fade to black: importation and counterfeit drugs.
    Liang BA
    Am J Law Med; 2006; 32(2-3):279-323. PubMed ID: 16927613
    [No Abstract]   [Full Text] [Related]  

  • 22. Poor-quality medical products: time to address substandards, not only counterfeits.
    Ravinetto RM; Boelaert M; Jacobs J; Pouget C; Luyckx C
    Trop Med Int Health; 2012 Nov; 17(11):1412-6. PubMed ID: 22909082
    [No Abstract]   [Full Text] [Related]  

  • 23. [Counterfeit drugs are everyone's business].
    Williamson L
    Krankenpfl Soins Infirm; 2014; 107(8):22-3. PubMed ID: 25141506
    [No Abstract]   [Full Text] [Related]  

  • 24. Trojan drugs: counterfeit and mislabeled pharmaceuticals in the legitimate market.
    deKieffer D
    Am J Law Med; 2006; 32(2-3):325-49. PubMed ID: 16927614
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA warning: New batch of fake bevacizumab found.
    Kuehn BM
    JAMA; 2013 Mar; 309(9):864. PubMed ID: 23462766
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of drug shortages across two countries during pre-pandemic and pandemic times.
    Cameron EE; Bushell MA
    Res Social Adm Pharm; 2021 Sep; 17(9):1570-1573. PubMed ID: 33323334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical counterfeiting and the RFID technology intervention.
    Coustasse A; Arvidson C; Rutsohn P
    J Hosp Mark Public Relations; 2010 Jul; 20(2):100-15. PubMed ID: 20582850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding and fighting the medicine counterfeit market.
    Dégardin K; Roggo Y; Margot P
    J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the problem of counterfeit medications in the United Kingdom.
    Jackson G; Patel S; Khan S
    Int J Clin Pract; 2012 Mar; 66(3):241-50. PubMed ID: 22070229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving the drug quality and safety net.
    Carter A
    J Diabetes Sci Technol; 2014 Jul; 8(4):898-9. PubMed ID: 24876419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA recognition of first-world drug regulators as means of relieving U.S. drug shortages.
    Hunnisett-Dritz D
    Am J Health Syst Pharm; 2012 Oct; 69(19):1626, 1628. PubMed ID: 22997113
    [No Abstract]   [Full Text] [Related]  

  • 32. Strategic plan aims to curb drug shortages.
    Cancer Discov; 2014 Jan; 4(1):7. PubMed ID: 24402927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Counterfeit Medicines in Internet and the Fakeshare European Project: Experiences and Activities in Spain].
    Catalán-Matamoros D; González-Ochando N; Pecharroman-Arribas H; Fernández-Muelas A; Bentolila-Benchimol SS; IbarraLorente M
    Rev Esp Salud Publica; 2016 Aug; 90():e1-e14. PubMed ID: 27529446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles for pharmacy in combatting counterfeit drugs.
    Ziance RJ
    J Am Pharm Assoc (2003); 2008; 48(4):e71-88; quiz e89-91. PubMed ID: 18653407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].
    Tamir O; Friedman N; Furman-Assaf S; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):466-9, 479. PubMed ID: 21465763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug shortages and ensuring the U.S. supply of needed pharmaceuticals.
    Somberg JC
    Am J Ther; 2012 Mar; 19(2):65. PubMed ID: 22394999
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?
    Dooley K; Sullivan JA
    Health Care Law Mon; 2010 Oct; 2010(10):2-8. PubMed ID: 21302589
    [No Abstract]   [Full Text] [Related]  

  • 38. An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain.
    Cuomo RE; Mackey TK
    BMJ Open; 2014 Dec; 4(12):e006657. PubMed ID: 25468507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rise in online pharmacies sees counterfeit drugs go global.
    Clark F
    Lancet; 2015 Oct; 386(10001):1327-8. PubMed ID: 26460765
    [No Abstract]   [Full Text] [Related]  

  • 40. Trends in counterfeit drugs and pharmaceuticals before and during COVID-19 pandemic.
    Ziavrou KS; Noguera S; Boumba VA
    Forensic Sci Int; 2022 Sep; 338():111382. PubMed ID: 35882074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.